Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia? by Felicetto Ferrara, Alessandra Picardi

Get full text

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia by Felicetto Ferrara, Federica Lessi, Orsola Vitagliano, Erika Birkenghi, Giuseppe Rossi

Get full text

Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy by Roberto Cairoli, Gianluca Furneri, Roberto Di Virgilio, Barbara Veggia, Felicetto Ferrara

Get full text

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia? by Federico Lussana, Paola Minetto, Felicetto Ferrara, Sabina Chiaretti, Giorgina Specchia, Renato Bassan

Get full text

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? by Massimo Bernardi, Felicetto Ferrara, Matteo Giovanni Carrabba, Sara Mastaglio, Francesca Lorentino, Luca Vago, Luca Vago, Fabio Ciceri, Fabio Ciceri

Get full text

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy by Raffaele Palmieri, Atto Billio, Felicetto Ferrara, Sara Galimberti, Roberto M. Lemoli, Roberto M. Lemoli, Elisabetta Todisco, Federico Moretti, Adriano Venditti

Get full text

PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS. by Federica Lessi, Erika Borlenghi, Chiara Sartor, Calogero Vetro, Ernesta Audisio, Federico Vincenzo, Andrea Visentin, Federica Loscocco, Carmela Gurrieri, Livio Trentin, Felicetto Ferrara

Get full text

Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study) by Maria Paola Martelli, Nicola Di Renzo, Antonio Curti, Nicola Stefano Fracchiolla, Luca Maurillo, Morena Caira, Paola Finsinger, Giuliana Gualberti, Felicetto Ferrara, Attilio Olivieri

Get full text

Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study by Federica Lessi, Marica Laurino, Cristina Papayannidis, Orsola Vitagliano, Francesco Grimaldi, Davide Lazzarotto, Michele Gottardi, Elena Crisà, Marta Riva, Gianluigi Reda, Mario Ermani, Gianpietro Semenzato, Livio Trentin, Felicetto Ferrara

Get full text

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation by Flavia Antonucci, Serena Marotta, Maria Celentano, Mariangela Pedata, Cira Riccardi, Cristina Luise, Angela Carobene, Simona Maria Muggianu, Assunta Viola, Mafalda Caputo, Stefania Leone, Ilaria Migliaccio, Barbara Pocali, Mirella Alberti, Claudio Falco, Mario Toriello, Felicetto Ferrara, Alessandra Picardi, Alessandra Picardi

Get full text

P663: MULTICENTER, PROSPECTIVE AND RETROSPECTIVE OBSERVATIONAL COHORT STUDY OF PONATINIB IN PATIENTS WITH CML IN ITALY: LONG-TERM FOLLOW-UP RESULTS OF THE OITI TRIAL by Massimo Breccia, Alessandra Iurlo, Felicetto Ferrara, Immacolata Attolico, Alessandra Malato, Massimiliano Bonifacio, Anna Rita Scortechini, Elisabetta Abruzzese, Grazia Sanpaolo, Nicola DI Renzo, Monia Lunghi, Stefana Impera, Fausto Castagnetti, Mario Tiribelli, Marco Santoro, Francesca Lunghi, Alessandro Maggi, Valeria Sargentini, Alfonso Piciocchi, Claudia Tringali, Luigiana Luciano

Get full text

P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY by Mario Annunziata, Monia Lunghi, Fabio Giglio, Matteo Leoncin, Michelina Dargenio, Massimiliano Bonifacio, Marco De Gobbi, Carla Mazzone, Roberta Agrippino, Davide Lazzarotto, Elisa Roncoroni, Marzia Defina, Nicola Fracchiolla, Fabio Guolo, Maria Ilaria Del Principe, Barbara Scappini, Antonino Mulè, Maria Ciccone, Crescenza Pasciolla, Felicetto Ferrara, Giovanni Pizzolo, Robin Foà, Sabina Chiaretti

Get full text

Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience by Rossella Iula, Danilo De Novellis, Danilo De Novellis, Fabio Trastulli, Roberta Della Pepa, Raffaele Fontana, Angela Carobene, Maria Di Perna, Alessandro D’Ambrosio, Martina Romano, Aldo Leone, Laura De Fazio, Alfonso Fiumarella, Giuseppe Gaeta, Violetta Marafioti, Serafina Barbato, Salvatore Palmieri, Stefano Rocco, Bianca Serio, Catello Califano, Fabrizio Pane, Felicetto Ferrara, Valentina Giudice, Valentina Giudice, Carmine Selleri, Carmine Selleri, Lucio Catalano

Get full text

P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA by Adriano Venditti, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria Del Principe, Raffaele Palmieri, Stefano Soddu, Federico Moretti, Prassede Salutari, Maurizio Martelli, Maria Paola Martelli, Mario Luppi, Alessandro Pulsoni, Francesco Zaja, Roberto Cairoli, Fabrizio Pane, Sergio Siragusa, Renato Bassan, Michela Rondoni, Milena Mirabile, Antonino Mulè, Germana Beltrami, Patrizia Zappasodi, Laura Cudillo, Andrea Mengarelli, Antonio Curti, Felicetto Ferrara, Giovanni Rossi, Ernesta Audisio, Giuseppina Spinosa, Alessia Tieghi, Monica Bocchia, Vincenza Martini, Catello Califano, Luigi Rigacci, Agostino Tafuri, Michele Gottardi, Paola Fazi, Marco Vignetti, Francesco Buccisano

Get full text

Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study by Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica

Get full text

P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIAN, MULTI-RESISTANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENT POPULATION by Massimo Breccia, Antonella Russo Rossi, Valentina Giai, Bruno Martino, Carmen Fava, Mario Annunziata, Elisabetta Abruzzese, Gianni Binotto, Claudia Baratè, Aurelio Pio Nardozza, Alessandra Misto, Paola Coco, Valeria Calafiore, Maria Cristina Carraro, Federica Cattina, Francesco Cavazzini, Maria Teresa Corsetti, Lara Crucitti, Monica Crugnola, Paolo Ditonno, Ambra DI Veroli, Anna Ermacora, Felicetto Ferrara, Angelo Genua, Antonella Gozzini, Stefana Impera, Alessandra Iurlo, Luciano Levato, Luigiana Luciano, Maria Cristina Miggiano, Marco De Gobbi, Marco Santoro, Barbara Scappini, Anna Rita Scortechini, Andrea Patriarca, Serena Rosati, Sabina Russo, Rosaria Sancetta, Grazia Sanpaolo, Teresa Maria Santeramo, Silvia Sibilla, Federica Sorà, Paolo Sportoletti, Fabio Stagno, Elena Trabacchi, Fausto Castagnetti

Get full text